Neutropenia
New neutropenia research from E.J. Ip and co-researchers described
Published in Hematology Week, September 22nd, 2008
"The objective of this study was to compare low-dose filgrastim (150 mu g/day subcutaneously) with standard-dose subcutaneous filgrastim (300 mu g/day) or lenograstim (263 mu g/day) in preventing febrile neutropenia and hospitalizations in breast cancer patients receiving the docetaxel-doxorubicin-cyclophosphamide regimen. A single-center retrospective data analysis was performed involving 22 adult women with breast cancer who concurrently received the clocetaxeldoxorubicin-cyclophospharnicle chemotherapy regimen and low-dose filgrastim from March 2004 to February 2007," investigators in the United States report.
"Data from this study were compared to previously...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2008-09-22)
More Articles from Hematology Week
- American Psychological Association
Older adults can take medicines more safely and effectively by charting their daily routines - American Heart Association
Hospitals Participating in Get With the Guidelines(SM) Program Follow Heart Attack Treatment Guidelines Better Than Others - Bone Marrow
Data on bone marrow reported by researchers at Sahlgrenska University - Bone Marrow Transplantation
New bone marrow transplantation study findings recently were reported by researchers at University of Nevada, Medical Department - C Reactive Protein
Research from University of Milan reveals new findings on c reactive protein - Candidiasis
Reports from University of Porto advance knowledge in candidiasis - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
